These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39167579)

  • 1. COMPREHENSIVE MOLECULAR PROFILING OF UVEAL MELANOMA EVALUATED WITH GENE EXPRESSION PROFILING, PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA EXPRESSION, AND NEXT-GENERATION SEQUENCING.
    Alsoudi AF; Skrehot HC; Chévez-Barrios P; Divatia M; De La Garza M; Bretana ME; Schefler AC
    Retina; 2024 Sep; 44(9):1580-1589. PubMed ID: 39167579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
    Schefler AC; Koca E; Bernicker EH; Correa ZM
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
    Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
    JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma.
    Field MG; Decatur CL; Kurtenbach S; Gezgin G; van der Velden PA; Jager MJ; Kozak KN; Harbour JW
    Clin Cancer Res; 2016 Mar; 22(5):1234-42. PubMed ID: 26933176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma.
    Cai L; Paez-Escamilla M; Walter SD; Tarlan B; Decatur CL; Perez BM; Harbour JW
    Am J Ophthalmol; 2018 Nov; 195():154-160. PubMed ID: 30092184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
    Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
    JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New concepts in the molecular understanding of uveal melanoma.
    Reichstein D
    Curr Opin Ophthalmol; 2017 May; 28(3):219-227. PubMed ID: 28257297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-Gene Expression Profile and
    Harbour JW; Correa ZM; Schefler AC; Mruthyunjaya P; Materin MA; Aaberg TA; Skalet AH; Reichstein DA; Weis E; Kim IK; Fuller TS; Demirci H; Piggott KD; Williams BK; Shildkrot E; Capone A; Oliver SC; Walter SD; Mason J; Char DH; Altaweel M; Wells JR; Duker JS; Hovland PG; Gombos DS; Tsai T; Javid C; Marr BP; Gao A; Decatur CL; Dollar JJ; Kurtenbach S; Zhang S
    J Clin Oncol; 2024 Oct; 42(28):3319-3329. PubMed ID: 39052972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of GNAQ, GNA11, SF3B1, EIF1AX, PLCB4 and CYSLTR in Uveal Melanoma in Chinese Patients.
    Hou C; Xiao L; Ren X; Tang F; Guo B; Zeng W; Liang C; Yan N
    Ophthalmic Res; 2020; 63(3):358-368. PubMed ID: 31614358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Expression Profiling Prognostication of Posterior Uveal Melanoma: Does Size Matter?
    Binkley EM; Bena JF; Davanzo JM; Hinz C; Boldt HC; Singh AD
    Ophthalmol Retina; 2020 Jun; 4(6):620-629. PubMed ID: 32081600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal rearrangements in uveal melanoma: Chromothripsis.
    van Poppelen NM; Yavuzyigitoglu S; Smit KN; Vaarwater J; Eussen B; Brands T; Paridaens D; Kiliç E; de Klein A
    Genes Chromosomes Cancer; 2018 Sep; 57(9):452-458. PubMed ID: 29726589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferentially Expressed Antigen in Melanoma Immunohistochemistry Labeling in Uveal Melanomas.
    Ahmadian SS; Dryden IJ; Naranjo A; Toland A; Cayrol RA; Born DE; Egbert PS; Brown RA; Mruthyunjaya P; Lin JH
    Ocul Oncol Pathol; 2022 Jun; 8(2):133-140. PubMed ID: 35959159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CORRELATION OF GENE EXPRESSION PROFILE STATUS AND AMERICAN JOINT COMMISSION ON CANCER STAGE IN UVEAL MELANOMA.
    Berry DE; Schefler AC; Seider MI; Materin M; Stinnett S; Mruthyunjaya P;
    Retina; 2020 Feb; 40(2):214-224. PubMed ID: 31972790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases.
    Yavuzyigitoglu S; Koopmans AE; Verdijk RM; Vaarwater J; Eussen B; van Bodegom A; Paridaens D; Kiliç E; de Klein A;
    Ophthalmology; 2016 May; 123(5):1118-28. PubMed ID: 26923342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Uveal Melanoma Metastatic Rate With Stochastic Mutation Rate and Type of Mutation.
    Szalai E; Jiang Y; van Poppelen NM; Jager MJ; de Klein A; Kilic E; Grossniklaus HE
    JAMA Ophthalmol; 2018 Oct; 136(10):1115-1120. PubMed ID: 30073324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.
    Royer-Bertrand B; Torsello M; Rimoldi D; El Zaoui I; Cisarova K; Pescini-Gobert R; Raynaud F; Zografos L; Schalenbourg A; Speiser D; Nicolas M; Vallat L; Klein R; Leyvraz S; Ciriello G; Riggi N; Moulin AP; Rivolta C
    Am J Hum Genet; 2016 Nov; 99(5):1190-1198. PubMed ID: 27745836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.
    Field MG; Durante MA; Decatur CL; Tarlan B; Oelschlager KM; Stone JF; Kuznetsov J; Bowcock AM; Kurtenbach S; Harbour JW
    Oncotarget; 2016 Sep; 7(37):59209-59219. PubMed ID: 27486988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.
    Akin-Bali DF
    Ophthalmic Genet; 2021 Dec; 42(6):732-743. PubMed ID: 34353217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma.
    Smit KN; van Poppelen NM; Vaarwater J; Verdijk R; van Marion R; Kalirai H; Coupland SE; Thornton S; Farquhar N; Dubbink HJ; Paridaens D; de Klein A; Kiliç E
    Mod Pathol; 2018 May; 31(5):763-771. PubMed ID: 29327717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.